ABHMC II, LLC

Track

Insider profile

ABHMC II, LLC's trades of Immunome Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Immunome Inc (IMNM)
Transaction date
Proposed sale
Price
145.18
Quantity 40,070
Value US$3,396,825
US Immunome Inc (IMNM)
Transaction date
Proposed sale
Price
474.14
Quantity 18,688
Value US$4,836,121
US Immunome Inc (IMNM)
Transaction date
Proposed sale
Price
117.80
Quantity 34,029
Value US$1,845,685
US Immunome Inc (IMNM)
Transaction date
Proposed sale
Price
21.04
Quantity 100,000
Value US$2,104,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-06 2026-08-06
US Immunome Inc (IMNM)
PrS Proposed sale
40,070
145.18
US$3,396,825 		40,070 145.18 US$3,396,825
2026-07-06 2026-07-06
US Immunome Inc (IMNM)
PrS Proposed sale
18,688
474.14
US$4,836,121 		18,688 474.14 US$4,836,121
2026-07-02 2026-07-02
US Immunome Inc (IMNM)
PrS Proposed sale
34,029
117.80
US$1,845,685 		34,029 117.80 US$1,845,685
2026-06-30 2026-06-30
US Immunome Inc (IMNM)
PrS Proposed sale
100,000
21.04
US$2,104,000 		100,000 21.04 US$2,104,000